潛伏性結核感染檢測市場規模、佔有率和成長分析：按檢測類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球潛伏性結核病感染檢測市場價值為 20.1 億美元，預計到 2025 年將成長至 21.3 億美元，到 2033 年將成長至 33.7 億美元，在預測期（2026-2033 年）內複合年成長率為 5.9%。

全球潛伏性結核病（潛伏性結核病）感染檢測市場的發展動力源於控制感染傳播和降低醫療成本的需求，其關鍵在於識別無症狀帶原者並預防其發展為活動性結核病。該市場涵蓋診斷試劑、即時檢測、檢查室基礎設施和分析軟體，凸顯了早期檢測的重要性。歷史上，該市場已從結核菌素皮膚試驗轉向更先進的分子診斷和數位化解決方案。日益重視系統性潛伏性結核病篩檢的政策顯著推動了市場成長，進而增加了對精準且擴充性檢測的需求。此外，人工智慧技術正在改善免疫分析中的訊號檢測，提升影像解讀的靈敏度，並最終簡化檢測流程，提高效率。這種動態環境為提供檢驗的檢測方法和整合解決方案的公司帶來了巨大的商機。

全球潛伏性結核感染檢測市場促進因素

隨著醫療專業人員和公共衛生組織日益認知到檢測潛伏性結核感染的重要性，篩檢計畫和診斷活動也越來越受到重視。這種意識的提高推動了對先進檢測技術的投資，並促使針對高風險族群實施有針對性的檢測策略。透過強調早期檢測，相關人員以為患者提供預防性護理方案，從而最大限度地降低疾病進展的風險。這項持續的努力不僅創造了對高靈敏度、擴充性的潛伏性結核診斷解決方案的持續需求，而且還推動了市場廣泛滲透，並促進了產品研發的創新。

全球潛伏性結核感染檢測市場面臨的限制因素

在許多地區，由於可靠的確診服務有限，臨床醫生不願進行潛伏性結核感染篩檢，阻礙了初次檢測呈陽性患者的後續追蹤。當確診途徑複雜或完全不存在時，醫療機構往往不願意將新的檢測技術納入常規診療流程，導致其普及率低。這種診斷有效性的不確定性阻礙了檢查室的投資，並限制了潛伏性結核檢測在綜合醫療保健系統中的整合。最終，這會限制市場成長，並阻礙資源匱乏地區部署檢測解決方案。

全球潛伏性結核感染檢測市場趨勢

全球潛伏性結核病（CTU）檢測市場正呈現出顯著的趨勢，即在基層醫療機構和社區環境中擴大檢測活動。隨著分散式醫療服務在國家計畫和私人醫療機構中日益普及，全科診所的常規風險評估和推廣篩檢變得愈發重要。這種方法能夠加強轉診途徑，改善病患就診流程，並最終減少社會歧視，提高醫療服務的可近性。相關人員正透過以下方式加速潛伏性感染的早期發現：重點培訓醫護人員、與具有文化敏感性的社區互動以及建立本地夥伴關係。這種積極主動的策略不僅有助於預防性干預措施的實施，還能與現有的醫療服務無縫銜接，尤其對服務不足和偏遠地區的居民而言更是如此。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球潛伏性結核感染檢測市場規模：依檢測類型分類

• 結核菌素皮膚試驗（TST）
• 干擾素γ釋放試驗（IGRA）

全球潛伏性結核感染檢測市場規模：依應用領域分類。

• 診斷中心
• 醫院和診所
• 研究機構
• 其他

全球潛伏性結核感染檢測市場規模：依最終用戶分類

• 高危險群
• 醫療保健專業人員
• 移民和旅行者
• 其他

全球潛伏性結核感染檢測市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Qiagen
• Danaher
• Roche Holding
• Revvity
• Becton Dickinson
• Oxford Immunotec
• BioMerieux
• Sanofi
• Merck KGaA
• Lupin
• Sun Pharmaceutical Industries
• Siemens Energy
• Abbott Laboratories
• Teva Pharmaceutical
• Hologic
• Fujifilm Holdings
• Standard Diagnostics
• SD Biosensor
• Lionex
• MyLife Technologies

結論與建議

Global Latent Tuberculosis Infection Detection Market size was valued at USD 2.01 Billion in 2024 and is poised to grow from USD 2.13 Billion in 2025 to USD 3.37 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026-2033).

The global latent tuberculosis infection detection market is driven by the need to identify asymptomatic carriers to prevent the progression to active tuberculosis, thereby mitigating transmission and reducing healthcare costs. This market encompasses diagnostic assays, point-of-care tests, laboratory infrastructure, and analytics software, emphasizing the importance of early detection. Historically, it has transitioned from tuberculin skin testing to more advanced molecular and digital solutions. Growth is significantly fueled by evolving policies that prioritize systematic latent screening, leading to increased demand for accurate and scalable tests. Additionally, AI technology enhances sensitivity by refining immune assay signal detection and improving image interpretation, ultimately streamlining testing processes and increasing efficiency. This dynamic environment presents opportunities for firms that offer validated assays and integrated solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Latent Tuberculosis Infection Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Latent Tuberculosis Infection Detection Market Segments Analysis

Global latent tuberculosis infection detection market is segmented by test type, application, end-user focus and region. Based on test type, the market is segmented into Tuberculin Skin Test (TST) and Interferon-Gamma Release Assay (IGRA). Based on application, the market is segmented into Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others. Based on end-user focus, the market is segmented into High-Risk Populations, Healthcare Workers, Immigrants and Travelers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Latent Tuberculosis Infection Detection Market

The increasing recognition among healthcare professionals and public health organizations regarding the critical need to detect latent tuberculosis infections has resulted in a heightened focus on screening programs and diagnostic efforts. This heightened awareness promotes investments in advanced testing technologies and fosters the implementation of targeted detection strategies aimed at high-risk groups. By emphasizing early identification, stakeholders are able to connect individuals with preventive care options, thereby minimizing the risk of disease progression. This ongoing commitment not only creates a sustained demand for sensitive and scalable diagnostic solutions for latent TB but also drives widespread market adoption and encourages innovation in product development.

Restraints in the Global Latent Tuberculosis Infection Detection Market

The limited access to dependable confirmatory diagnostic services in numerous regions undermines clinicians' confidence in launching latent tuberculosis infection screening initiatives and hinders follow-up on positive initial results. When pathways for confirmation are either intricate or non-existent, healthcare providers tend to be hesitant about adopting new detection technologies into standard practice, resulting in lower adoption rates. This uncertainty surrounding diagnostic validation also deters laboratory investments and restricts the incorporation of latent TB testing into comprehensive care systems, ultimately constraining market growth and impeding the introduction of detection solutions in areas that lack adequate resources.

Market Trends of the Global Latent Tuberculosis Infection Detection Market

The Global Latent Tuberculosis Infection Detection market is witnessing a significant trend toward expanding detection efforts within primary healthcare and community settings. As decentralized care gains traction among national programs and private providers, there is a heightened emphasis on routine risk assessments during general consultations and outreach screenings. This approach leads to strengthened referral pathways and improved patient navigation, ultimately reducing stigma and enhancing accessibility. By focusing on workforce training, culturally tailored community engagement, and fostering local partnerships, stakeholders are enhancing early identification of latent infections. This proactive strategy not only facilitates preventive interventions but also integrates seamlessly with existing healthcare services, particularly for underserved and remote populations.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Latent Tuberculosis Infection Detection Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Tuberculin Skin Test (TST)
• Interferon-Gamma Release Assay (IGRA)

Global Latent Tuberculosis Infection Detection Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostic Centers
• Hospitals and Clinics
• Research Institutes
• Others

Global Latent Tuberculosis Infection Detection Market Size by End-User Focus & CAGR (2026-2033)

• Market Overview
• High-Risk Populations
• Healthcare Workers
• Immigrants and Travelers
• Others

Global Latent Tuberculosis Infection Detection Market Size & CAGR (2026-2033)

• North America (Test Type, Application, End-User Focus)
  • US
  • Canada
• Europe (Test Type, Application, End-User Focus)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Application, End-User Focus)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Application, End-User Focus)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Application, End-User Focus)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Immunotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Energy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lionex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyLife Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations